Industry Insights & Networking
Three-quarters of clinical trial protocols now need at least one substantial amendment after they’re finalized, up from just over half a decade ago. Each one costs a median of...
Talk to enough biotech teams heading into a pre-IND meeting and you’ll hear the same thing: “We had a plan. We thought we were ready.” The gap between feeling ready...
Half the field says AI-customized CVs are ATS gold. The other half says they get auto-rejected. Both are partially right, here’s the evidence. The life sciences job market has...
Hiring a full-time scientist to solve a three-month problem is like buying a restaurant because you want dinner. Here’s the math There are things companies buy without really...
If you’ve been applying for life sciences roles and hearing nothing back, the problem may not be your resume. Some of the jobs you applied to were never going to be filled. Two...
